Global Acute Kidney Injury Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 283472
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Acute Kidney Injury Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Acute Kidney Injury Treatment market size is estimated to be worth US$ 1241 million in 2021 and is forecast to a readjusted size of USD 1614.3 million by 2028 with a CAGR of 3.8% during review period. Hospitals accounting for % of the Acute Kidney Injury Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prerenal Acute Kidney Injury segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Acute Kidney Injury Treatment include Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, LG Chem, and Asahi Kasei Medical Co., Ltd., etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Acute Kidney Injury Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Prerenal Acute Kidney Injury

Postrenal Acute Kidney Injury

Intrinsic Renal Acute Kidney Injury

Market segment by Application, can be divided into

Hospitals

Ambulatory Surgical Centers

Others

Market segment by players, this report covers

Quark Pharmaceuticals, Inc.

Baxter International, Inc.

Fresenius Medical Care AG & Co. KGaA

LG Chem

Asahi Kasei Medical Co., Ltd.

B. Braun Melsungen AG

Angion Biomedica Corp

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Acute Kidney Injury Treatment product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Acute Kidney Injury Treatment, with revenue, gross margin and global market share of Acute Kidney Injury Treatment from 2019 to 2022.

Chapter 3, the Acute Kidney Injury Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Acute Kidney Injury Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Acute Kidney Injury Treatment research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Acute Kidney Injury Treatment

1.2 Classification of Acute Kidney Injury Treatment by Type

1.2.1 Overview: Global Acute Kidney Injury Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Acute Kidney Injury Treatment Revenue Market Share by Type in 2021

1.2.3 Prerenal Acute Kidney Injury

1.2.4 Postrenal Acute Kidney Injury

1.2.5 Intrinsic Renal Acute Kidney Injury

1.3 Global Acute Kidney Injury Treatment Market by Application

1.3.1 Overview: Global Acute Kidney Injury Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Global Acute Kidney Injury Treatment Market Size & Forecast

1.5 Global Acute Kidney Injury Treatment Market Size and Forecast by Region

1.5.1 Global Acute Kidney Injury Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Acute Kidney Injury Treatment Market Size by Region, (2017-2022)

1.5.3 North America Acute Kidney Injury Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Acute Kidney Injury Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Acute Kidney Injury Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Acute Kidney Injury Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Acute Kidney Injury Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Acute Kidney Injury Treatment Market Drivers

1.6.2 Acute Kidney Injury Treatment Market Restraints

1.6.3 Acute Kidney Injury Treatment Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Quark Pharmaceuticals, Inc.

2.1.1 Quark Pharmaceuticals, Inc. Details

2.1.2 Quark Pharmaceuticals, Inc. Major Business

2.1.3 Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Product and Solutions

2.1.4 Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Quark Pharmaceuticals, Inc. Recent Developments and Future Plans

2.2 Baxter International, Inc.

2.2.1 Baxter International, Inc. Details

2.2.2 Baxter International, Inc. Major Business

2.2.3 Baxter International, Inc. Acute Kidney Injury Treatment Product and Solutions

2.2.4 Baxter International, Inc. Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Baxter International, Inc. Recent Developments and Future Plans

2.3 Fresenius Medical Care AG & Co. KGaA

2.3.1 Fresenius Medical Care AG & Co. KGaA Details

2.3.2 Fresenius Medical Care AG & Co. KGaA Major Business

2.3.3 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Product and Solutions

2.3.4 Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Fresenius Medical Care AG & Co. KGaA Recent Developments and Future Plans

2.4 LG Chem

2.4.1 LG Chem Details

2.4.2 LG Chem Major Business

2.4.3 LG Chem Acute Kidney Injury Treatment Product and Solutions

2.4.4 LG Chem Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 LG Chem Recent Developments and Future Plans

2.5 Asahi Kasei Medical Co., Ltd.

2.5.1 Asahi Kasei Medical Co., Ltd. Details

2.5.2 Asahi Kasei Medical Co., Ltd. Major Business

2.5.3 Asahi Kasei Medical Co., Ltd. Acute Kidney Injury Treatment Product and Solutions

2.5.4 Asahi Kasei Medical Co., Ltd. Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Asahi Kasei Medical Co., Ltd. Recent Developments and Future Plans

2.6 B. Braun Melsungen AG

2.6.1 B. Braun Melsungen AG Details

2.6.2 B. Braun Melsungen AG Major Business

2.6.3 B. Braun Melsungen AG Acute Kidney Injury Treatment Product and Solutions

2.6.4 B. Braun Melsungen AG Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 B. Braun Melsungen AG Recent Developments and Future Plans

2.7 Angion Biomedica Corp

2.7.1 Angion Biomedica Corp Details

2.7.2 Angion Biomedica Corp Major Business

2.7.3 Angion Biomedica Corp Acute Kidney Injury Treatment Product and Solutions

2.7.4 Angion Biomedica Corp Acute Kidney Injury Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Angion Biomedica Corp Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Acute Kidney Injury Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Acute Kidney Injury Treatment Players Market Share in 2021

3.2.2 Top 10 Acute Kidney Injury Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Acute Kidney Injury Treatment Players Head Office, Products and Services Provided

3.4 Acute Kidney Injury Treatment Mergers & Acquisitions

3.5 Acute Kidney Injury Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Acute Kidney Injury Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Acute Kidney Injury Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Acute Kidney Injury Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Acute Kidney Injury Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Acute Kidney Injury Treatment Revenue by Type (2017-2028)

6.2 North America Acute Kidney Injury Treatment Revenue by Application (2017-2028)

6.3 North America Acute Kidney Injury Treatment Market Size by Country

6.3.1 North America Acute Kidney Injury Treatment Revenue by Country (2017-2028)

6.3.2 United States Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Acute Kidney Injury Treatment Revenue by Type (2017-2028)

7.2 Europe Acute Kidney Injury Treatment Revenue by Application (2017-2028)

7.3 Europe Acute Kidney Injury Treatment Market Size by Country

7.3.1 Europe Acute Kidney Injury Treatment Revenue by Country (2017-2028)

7.3.2 Germany Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

7.3.3 France Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Acute Kidney Injury Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Acute Kidney Injury Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Acute Kidney Injury Treatment Market Size by Region

8.3.1 Asia-Pacific Acute Kidney Injury Treatment Revenue by Region (2017-2028)

8.3.2 China Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

8.3.5 India Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Acute Kidney Injury Treatment Revenue by Type (2017-2028)

9.2 South America Acute Kidney Injury Treatment Revenue by Application (2017-2028)

9.3 South America Acute Kidney Injury Treatment Market Size by Country

9.3.1 South America Acute Kidney Injury Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Acute Kidney Injury Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Acute Kidney Injury Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Acute Kidney Injury Treatment Market Size by Country

10.3.1 Middle East & Africa Acute Kidney Injury Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Acute Kidney Injury Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Acute Kidney Injury Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Acute Kidney Injury Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Acute Kidney Injury Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Acute Kidney Injury Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Acute Kidney Injury Treatment Revenue Market Share by Region (2023-2028)

Table 6. Quark Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Quark Pharmaceuticals, Inc. Major Business

Table 8. Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Product and Solutions

Table 9. Quark Pharmaceuticals, Inc. Acute Kidney Injury Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Baxter International, Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Baxter International, Inc. Major Business

Table 12. Baxter International, Inc. Acute Kidney Injury Treatment Product and Solutions

Table 13. Baxter International, Inc. Acute Kidney Injury Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Fresenius Medical Care AG & Co. KGaA Corporate Information, Head Office, and Major Competitors

Table 15. Fresenius Medical Care AG & Co. KGaA Major Business

Table 16. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Product and Solutions

Table 17. Fresenius Medical Care AG & Co. KGaA Acute Kidney Injury Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. LG Chem Corporate Information, Head Office, and Major Competitors

Table 19. LG Chem Major Business

Table 20. LG Chem Acute Kidney Injury Treatment Product and Solutions

Table 21. LG Chem Acute Kidney Injury Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Asahi Kasei Medical Co., Ltd. Corporate Information, Head Office, and Major Competitors

Table 23. Asahi Kasei Medical Co., Ltd. Major Business

Table 24. Asahi Kasei Medical Co., Ltd. Acute Kidney Injury Treatment Product and Solutions

Table 25. Asahi Kasei Medical Co., Ltd. Acute Kidney Injury Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. B. Braun Melsungen AG Corporate Information, Head Office, and Major Competitors

Table 27. B. Braun Melsungen AG Major Business

Table 28. B. Braun Melsungen AG Acute Kidney Injury Treatment Product and Solutions

Table 29. B. Braun Melsungen AG Acute Kidney Injury Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Angion Biomedica Corp Corporate Information, Head Office, and Major Competitors

Table 31. Angion Biomedica Corp Major Business

Table 32. Angion Biomedica Corp Acute Kidney Injury Treatment Product and Solutions

Table 33. Angion Biomedica Corp Acute Kidney Injury Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Global Acute Kidney Injury Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 35. Global Acute Kidney Injury Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 36. Breakdown of Acute Kidney Injury Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 37. Acute Kidney Injury Treatment Players Head Office, Products and Services Provided

Table 38. Acute Kidney Injury Treatment Mergers & Acquisitions in the Past Five Years

Table 39. Acute Kidney Injury Treatment New Entrants and Expansion Plans

Table 40. Global Acute Kidney Injury Treatment Revenue (USD Million) by Type (2017-2022)

Table 41. Global Acute Kidney Injury Treatment Revenue Share by Type (2017-2022)

Table 42. Global Acute Kidney Injury Treatment Revenue Forecast by Type (2023-2028)

Table 43. Global Acute Kidney Injury Treatment Revenue by Application (2017-2022)

Table 44. Global Acute Kidney Injury Treatment Revenue Forecast by Application (2023-2028)

Table 45. North America Acute Kidney Injury Treatment Revenue by Type (2017-2022) & (USD Million)

Table 46. North America Acute Kidney Injury Treatment Revenue by Type (2023-2028) & (USD Million)

Table 47. North America Acute Kidney Injury Treatment Revenue by Application (2017-2022) & (USD Million)

Table 48. North America Acute Kidney Injury Treatment Revenue by Application (2023-2028) & (USD Million)

Table 49. North America Acute Kidney Injury Treatment Revenue by Country (2017-2022) & (USD Million)

Table 50. North America Acute Kidney Injury Treatment Revenue by Country (2023-2028) & (USD Million)

Table 51. Europe Acute Kidney Injury Treatment Revenue by Type (2017-2022) & (USD Million)

Table 52. Europe Acute Kidney Injury Treatment Revenue by Type (2023-2028) & (USD Million)

Table 53. Europe Acute Kidney Injury Treatment Revenue by Application (2017-2022) & (USD Million)

Table 54. Europe Acute Kidney Injury Treatment Revenue by Application (2023-2028) & (USD Million)

Table 55. Europe Acute Kidney Injury Treatment Revenue by Country (2017-2022) & (USD Million)

Table 56. Europe Acute Kidney Injury Treatment Revenue by Country (2023-2028) & (USD Million)

Table 57. Asia-Pacific Acute Kidney Injury Treatment Revenue by Type (2017-2022) & (USD Million)

Table 58. Asia-Pacific Acute Kidney Injury Treatment Revenue by Type (2023-2028) & (USD Million)

Table 59. Asia-Pacific Acute Kidney Injury Treatment Revenue by Application (2017-2022) & (USD Million)

Table 60. Asia-Pacific Acute Kidney Injury Treatment Revenue by Application (2023-2028) & (USD Million)

Table 61. Asia-Pacific Acute Kidney Injury Treatment Revenue by Region (2017-2022) & (USD Million)

Table 62. Asia-Pacific Acute Kidney Injury Treatment Revenue by Region (2023-2028) & (USD Million)

Table 63. South America Acute Kidney Injury Treatment Revenue by Type (2017-2022) & (USD Million)

Table 64. South America Acute Kidney Injury Treatment Revenue by Type (2023-2028) & (USD Million)

Table 65. South America Acute Kidney Injury Treatment Revenue by Application (2017-2022) & (USD Million)

Table 66. South America Acute Kidney Injury Treatment Revenue by Application (2023-2028) & (USD Million)

Table 67. South America Acute Kidney Injury Treatment Revenue by Country (2017-2022) & (USD Million)

Table 68. South America Acute Kidney Injury Treatment Revenue by Country (2023-2028) & (USD Million)

Table 69. Middle East & Africa Acute Kidney Injury Treatment Revenue by Type (2017-2022) & (USD Million)

Table 70. Middle East & Africa Acute Kidney Injury Treatment Revenue by Type (2023-2028) & (USD Million)

Table 71. Middle East & Africa Acute Kidney Injury Treatment Revenue by Application (2017-2022) & (USD Million)

Table 72. Middle East & Africa Acute Kidney Injury Treatment Revenue by Application (2023-2028) & (USD Million)

Table 73. Middle East & Africa Acute Kidney Injury Treatment Revenue by Country (2017-2022) & (USD Million)

Table 74. Middle East & Africa Acute Kidney Injury Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Acute Kidney Injury Treatment Picture

Figure 2. Global Acute Kidney Injury Treatment Revenue Market Share by Type in 2021

Figure 3. Prerenal Acute Kidney Injury

Figure 4. Postrenal Acute Kidney Injury

Figure 5. Intrinsic Renal Acute Kidney Injury

Figure 6. Acute Kidney Injury Treatment Revenue Market Share by Application in 2021

Figure 7. Hospitals Picture

Figure 8. Ambulatory Surgical Centers Picture

Figure 9. Others Picture

Figure 10. Global Acute Kidney Injury Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Acute Kidney Injury Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Acute Kidney Injury Treatment Revenue Market Share by Region (2017-2028)

Figure 13. Global Acute Kidney Injury Treatment Revenue Market Share by Region in 2021

Figure 14. North America Acute Kidney Injury Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Acute Kidney Injury Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Acute Kidney Injury Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Acute Kidney Injury Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Acute Kidney Injury Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Acute Kidney Injury Treatment Market Drivers

Figure 20. Acute Kidney Injury Treatment Market Restraints

Figure 21. Acute Kidney Injury Treatment Market Trends

Figure 22. Quark Pharmaceuticals, Inc. Recent Developments and Future Plans

Figure 23. Baxter International, Inc. Recent Developments and Future Plans

Figure 24. Fresenius Medical Care AG & Co. KGaA Recent Developments and Future Plans

Figure 25. LG Chem Recent Developments and Future Plans

Figure 26. Asahi Kasei Medical Co., Ltd. Recent Developments and Future Plans

Figure 27. B. Braun Melsungen AG Recent Developments and Future Plans

Figure 28. Angion Biomedica Corp Recent Developments and Future Plans

Figure 29. Global Acute Kidney Injury Treatment Revenue Share by Players in 2021

Figure 30. Acute Kidney Injury Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 31. Global Top 3 Players Acute Kidney Injury Treatment Revenue Market Share in 2021

Figure 32. Global Top 10 Players Acute Kidney Injury Treatment Revenue Market Share in 2021

Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 34. Global Acute Kidney Injury Treatment Revenue Share by Type in 2021

Figure 35. Global Acute Kidney Injury Treatment Market Share Forecast by Type (2023-2028)

Figure 36. Global Acute Kidney Injury Treatment Revenue Share by Application in 2021

Figure 37. Global Acute Kidney Injury Treatment Market Share Forecast by Application (2023-2028)

Figure 38. North America Acute Kidney Injury Treatment Sales Market Share by Type (2017-2028)

Figure 39. North America Acute Kidney Injury Treatment Sales Market Share by Application (2017-2028)

Figure 40. North America Acute Kidney Injury Treatment Revenue Market Share by Country (2017-2028)

Figure 41. United States Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Canada Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Mexico Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 44. Europe Acute Kidney Injury Treatment Sales Market Share by Type (2017-2028)

Figure 45. Europe Acute Kidney Injury Treatment Sales Market Share by Application (2017-2028)

Figure 46. Europe Acute Kidney Injury Treatment Revenue Market Share by Country (2017-2028)

Figure 47. Germany Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. France Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. United Kingdom Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Russia Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Italy Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Asia-Pacific Acute Kidney Injury Treatment Sales Market Share by Type (2017-2028)

Figure 53. Asia-Pacific Acute Kidney Injury Treatment Sales Market Share by Application (2017-2028)

Figure 54. Asia-Pacific Acute Kidney Injury Treatment Revenue Market Share by Region (2017-2028)

Figure 55. China Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Japan Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. South Korea Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. India Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Southeast Asia Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Australia Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South America Acute Kidney Injury Treatment Sales Market Share by Type (2017-2028)

Figure 62. South America Acute Kidney Injury Treatment Sales Market Share by Application (2017-2028)

Figure 63. South America Acute Kidney Injury Treatment Revenue Market Share by Country (2017-2028)

Figure 64. Brazil Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Argentina Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Middle East and Africa Acute Kidney Injury Treatment Sales Market Share by Type (2017-2028)

Figure 67. Middle East and Africa Acute Kidney Injury Treatment Sales Market Share by Application (2017-2028)

Figure 68. Middle East and Africa Acute Kidney Injury Treatment Revenue Market Share by Country (2017-2028)

Figure 69. Turkey Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Saudi Arabia Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. UAE Acute Kidney Injury Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Methodology

Figure 73. Research Process and Data Source